InMode Confirms Receipt of Unsolicited Proposal
InMode (Nasdaq: INMD) announced that its board received an unsolicited proposal on June 17, 2026 from M.N.
Rhea-AI Summary
InMode (Nasdaq: INMD) announced that its board received an unsolicited proposal on June 17, 2026 from M.N. Business Strategy to acquire all outstanding ordinary shares it does not already own for $16.20 per share in cash via merger.
The board formed a special committee of independent directors to evaluate the proposal with advisors, in line with fiduciary duties. There is no assurance any transaction or strategic outcome will result, and the company expects to give no further updates unless legally required.
Positive
- Unsolicited all-cash proposal at $16.20 per INMD share
- Independent special committee established to evaluate the proposal
- Process framed around fiduciary duties and all shareholders' interests
Negative
- No assurance any transaction or strategic outcome will occur
- Unclear timing and terms of any potential transaction
- Company plans no further updates unless legally required
Details
News Market Reaction – INMD
In the Jun 24 session, INMD gained 10.79%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Cash offer price
- $16.20 per share
- Unsolicited cash merger proposal from MN Business Strategy
- Pre‑news share price
- $13.35
- INMD price before announcement of the unsolicited proposal
- Mizrahy ownership
- 4,299,226 shares (7.06%)
- Beneficial ownership reported in Schedule 13D/A
- Recent insider purchases
- 800,000 shares; US$10.7M
- Open‑market buys by Moshe Mizrahy over 60 days using personal funds
- Share repurchases
- 2.9 million shares
- Company repurchases reducing shares outstanding prior to 13D/A
- Shares outstanding (prior)
- 63,358,750 shares
- Outstanding as of Dec 31, 2025 before recent buybacks
- Shares outstanding (recent)
- 60,922,346 shares
- Outstanding as of April 9, 2026 per Schedule 13D/A
Historical Context
-
Board chair and CFO transitions with continuity support described.
-
Announcement of participation in multiple upcoming investor events.
-
Q1 2026 financial results and updated full‑year guidance details.
-
Q1 earnings date, preliminary revenue range, and reiterated FY guidance.
-
Needham healthcare conference fireside chat and investor meetings.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
special committee regulatory
fiduciary duties regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM,
The Board has approved formation of a special committee comprised solely of independent directors to evaluate the Proposal. The special committee will, in consultation with its advisors, evaluate the Proposal in accordance with its fiduciary duties and the best interests of the Company and all of its shareholders. There can be no assurance as to whether this evaluation will result in a transaction or any other strategic outcome for the Company, or as to the timing or terms of any such transaction or outcome. The Company does not intend to comment further on the special committee process or provide additional updates unless and until required to do so under applicable law or regulation.
About InMode Ltd.
The Company is a leading global provider of innovative medical technologies. The Company develops, manufactures and markets devices harnessing novel radiofrequency ("RF") technology. The Company strives to enable new emerging surgical procedures as well as improve existing treatments. The Company has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. For more information about the Company and its wide array of medical technologies, visit www.inmodemd.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. In some cases, forward-looking statements can be identified by terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "will," "would" or the negative of those terms or other comparable terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding the Proposal, the special committee's review and evaluation of the Proposal, the potential consummation of any transaction and the Company's future plans, objectives, expectations and intentions. These statements involve known and unknown risks, uncertainties, and other factors that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied. Such factors include, among others: uncertainties as to whether the special committee will determine that the Proposal or any alternative transaction is in the best interests of the Company and its shareholders; the risk that the Proposal may be withdrawn or modified; the possibility that competing offers or alternatives may or may not emerge; the risk that any transaction may not be consummated on the terms or timeline currently contemplated, or at all; and the other risks described in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise except as required by law.
Contacts
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-confirms-receipt-of-unsolicited-proposal-302809269.html
SOURCE InMode LTD
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.